Now in its 22nd year, New Developments in Oncology has offered a comprehensive view of advancements in treatments, techniques, and technologies for treating and managing cancer and blood diseases, as well as related symptoms. With a focus on the impact of research on health care delivery and outcomes, experts from across the country will engage in discussion of the state of the science and management of patients with breast cancer, thoracic malignancies, melanoma, lymphoma and prostate cancer. Cytokine Storm in Cancer therapy and COVID-19 as well as Castleman Disease will also be discussed. Through a collaborative, concerted effort between expert doctors and nurses, the Duke Cancer Network and Virginia Oncology Associates are excited to emphasize interprofessional approaches to cancer care, specifically in the management of patients with breast, lung, skin, and prostate cancer.